RethinkEd Funding: How Much Did They Raise & Key Investors

How Much Did RethinkEd Raise?
Funding & Key Investors

RethinkEd, a prominent player in the global health technology sector, has successfully secured significant capital to bolster its market position. The company has reached a cumulative valuation reflected by $12M, with its most recent strategic financing round contributing $10M to its growth trajectory. This infusion of capital underscores the firm's critical role in providing cloud-based treatment tools and clinical support to a diverse array of global stakeholders, ranging from Fortune 100 corporations to large-scale public school systems.

The progression of the company's financial history, starting from its initial Series A in 2008 and advancing through its Series C in 2014, highlights a consistent commitment to scaling its behavioral health infrastructure. By securing this latest investment, RethinkEd is well-positioned to further integrate its proprietary technology into the workflows of behavioral health professionals and educators worldwide.

What is RethinkEd?

RethinkEd

Software

Healthcare Software

Business Services

RethinkEd operates as a sophisticated health technology enterprise, specializing in cloud-based treatment tools, comprehensive training, and clinical support services. The company serves a vast network of clients, including nearly one-third of the Fortune 100, alongside major public school districts and health plans. Currently under the ownership of K1 Capital, a premier private equity firm focused on high-growth enterprise software, RethinkEd maintains a dominant market position by bridging the gap between complex behavioral health requirements and scalable digital solutions. Its platform is designed to enhance clinical outcomes while streamlining administrative burdens for large-scale organizations.

How much funding has RethinkEd raised?

RethinkEd has raised a total of $12M across 2 funding rounds:

2008

Series A

$2M

2014

Series C

$10M

Series A (2008): $2M, investors not publicly disclosed

Series C (2014): $10M led by Beringea and Arboretum Ventures

Key Investors in RethinkEd

Beringea

Beringea is an international venture capital firm that invests in high-growth businesses in the US and UK, focusing on empowering entrepreneurs to build billion-dollar companies.

Arboretum Ventures

Arboretum Ventures is a Midwest-based healthcare venture capital firm with over 20 years of experience in investing in innovative healthcare solutions.

Undisclosed Investors

What's next for RethinkEd?

Looking ahead, the strategic deployment of the $10M capital is expected to accelerate the company's product roadmap and expand its footprint in the enterprise health software market. With the backing of K1 Capital, RethinkEd is likely to prioritize the enhancement of its cloud-based clinical support tools and the expansion of its service offerings to meet the evolving needs of its Fortune 100 client base. The firm's focus remains on driving operational efficiency and improving behavioral health outcomes, leveraging its established infrastructure to capture further market share in the competitive health-tech landscape.

See full RethinkEd company page

See More Financial Insights